PL2399911T3 - Polimorfy febuksostatu - Google Patents
Polimorfy febuksostatuInfo
- Publication number
- PL2399911T3 PL2399911T3 PL10167344T PL10167344T PL2399911T3 PL 2399911 T3 PL2399911 T3 PL 2399911T3 PL 10167344 T PL10167344 T PL 10167344T PL 10167344 T PL10167344 T PL 10167344T PL 2399911 T3 PL2399911 T3 PL 2399911T3
- Authority
- PL
- Poland
- Prior art keywords
- febuxostat
- polymorphs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10167344.0A EP2399911B1 (en) | 2010-06-25 | 2010-06-25 | Polymorphs of Febuxostat |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2399911T3 true PL2399911T3 (pl) | 2016-01-29 |
Family
ID=43033242
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10167344T PL2399911T3 (pl) | 2010-06-25 | 2010-06-25 | Polimorfy febuksostatu |
PL11727454T PL2585445T3 (pl) | 2010-06-25 | 2011-06-24 | Polimorfy aktywnego składnika farmaceutycznego |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11727454T PL2585445T3 (pl) | 2010-06-25 | 2011-06-24 | Polimorfy aktywnego składnika farmaceutycznego |
Country Status (7)
Country | Link |
---|---|
US (1) | US8946441B2 (pl) |
EP (3) | EP2399911B1 (pl) |
CA (1) | CA2802937C (pl) |
DK (2) | DK2399911T3 (pl) |
ES (2) | ES2553584T3 (pl) |
PL (2) | PL2399911T3 (pl) |
WO (1) | WO2011161245A2 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2553584T3 (es) | 2010-06-25 | 2015-12-10 | Sandoz Ag | Polimorfos de Febuxostat |
CN103396378B (zh) * | 2013-07-29 | 2015-06-10 | 杭州朱养心药业有限公司 | 非布司他结晶 |
CZ27857U1 (cs) | 2014-12-12 | 2015-02-23 | Zentiva, K.S. | Formulace obsahující tuhý roztok febuxostatu |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1020454B2 (en) * | 1998-06-19 | 2013-01-23 | Teijin Pharma Limited | Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof |
PT1488790E (pt) | 2002-03-28 | 2014-10-10 | Teijin Pharma Ltd | Preparação sólida contendo uma forma de cristal único a de um derivado de ácido tiazolcarboxílico |
EP2532654A1 (en) * | 2009-06-10 | 2012-12-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of febuxostat |
CN101648926B (zh) | 2009-07-09 | 2011-11-16 | 石药集团欧意药业有限公司 | 一种非布司他晶型及其制备方法 |
CN101817801A (zh) * | 2009-08-12 | 2010-09-01 | 北京红惠新医药科技有限公司 | 2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸新晶型k及其他晶型的制备方法 |
ES2553584T3 (es) | 2010-06-25 | 2015-12-10 | Sandoz Ag | Polimorfos de Febuxostat |
-
2010
- 2010-06-25 ES ES10167344.0T patent/ES2553584T3/es active Active
- 2010-06-25 PL PL10167344T patent/PL2399911T3/pl unknown
- 2010-06-25 DK DK10167344.0T patent/DK2399911T3/en active
- 2010-06-25 EP EP10167344.0A patent/EP2399911B1/en not_active Revoked
-
2011
- 2011-06-24 ES ES11727454.8T patent/ES2553574T3/es active Active
- 2011-06-24 EP EP11727454.8A patent/EP2585445B1/en not_active Revoked
- 2011-06-24 PL PL11727454T patent/PL2585445T3/pl unknown
- 2011-06-24 DK DK11727454.8T patent/DK2585445T3/en active
- 2011-06-24 CA CA2802937A patent/CA2802937C/en not_active Expired - Fee Related
- 2011-06-24 WO PCT/EP2011/060630 patent/WO2011161245A2/en active Application Filing
- 2011-06-24 EP EP15181097.5A patent/EP2977372B1/en not_active Revoked
- 2011-06-24 US US13/702,077 patent/US8946441B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8946441B2 (en) | 2015-02-03 |
WO2011161245A2 (en) | 2011-12-29 |
US20130137734A1 (en) | 2013-05-30 |
WO2011161245A3 (en) | 2012-03-08 |
DK2399911T3 (en) | 2015-09-07 |
EP2585445B1 (en) | 2015-08-19 |
CA2802937C (en) | 2020-02-25 |
DK2585445T3 (en) | 2015-09-07 |
ES2553584T3 (es) | 2015-12-10 |
EP2399911B1 (en) | 2015-08-19 |
CA2802937A1 (en) | 2011-12-29 |
EP2977372A1 (en) | 2016-01-27 |
EP2977372B1 (en) | 2019-05-08 |
ES2553574T3 (es) | 2015-12-10 |
EP2585445A2 (en) | 2013-05-01 |
EP2399911A1 (en) | 2011-12-28 |
PL2585445T3 (pl) | 2016-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
IL246900A0 (en) | Polymorphs of Dronir | |
HK1204604A1 (en) | Stereoselective total synthesis of noribogaine | |
IL221170A0 (en) | Processes of synthesizing dihydropyridophthalazinone derivatives | |
IL222900A (en) | Forms of Rifaximin | |
EP2513116A4 (en) | POLYMORPH OF DARUNAVIR | |
ZA201300776B (en) | Improved process for the preparation of febuxostat | |
ZA201209620B (en) | Polymorphs of osi-906 | |
EP2563768A4 (en) | MANUFACTURE OF FEBUXOSTAT | |
GB201004096D0 (en) | Production of polyhydroalkanoates | |
EP2800747A4 (en) | POLYMORPHY OF PERAMPANEL | |
EP2524296A4 (en) | EXTENDING THE VISUALIZATION FUNCTIONALITY OF AN APPLICATION | |
IL222474A0 (en) | Method of synthesis | |
IL226041A0 (en) | Polymorphic forms of pebuxostat | |
IL223926A0 (en) | Synthesis of cyclopentaquinazolines | |
EP2680843A4 (en) | DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS | |
EP2619191A4 (en) | NEW POLYMORPHS OF FEBUXOSTAT | |
PL2399911T3 (pl) | Polimorfy febuksostatu | |
GB201008877D0 (en) | Biolgical control of molluscs | |
EP2393786A4 (en) | NEW POLYMORPHIC FROM LOPINAVIR | |
HK1160777A1 (en) | Novel use of neohesperidoside | |
TWM386182U (en) | Improved structure of seal | |
IL243319A0 (en) | Intermediates of teroarylpiperidine and piperazine derivatives | |
IL214275A0 (en) | Polymorphs of darunavir | |
IL233446A0 (en) | Polymorphic forms of paramphenel |